EZR and Atrophy: One local muscle injection of Ad-Ezrin, not Ad-Periaxin, dramatically increased the numbers of MyHC-I- and MyHC-II-positive fibers characterized by finer fibers, leading to the partial improvement in gastrocnemius muscle atrophy induced by PNI, indicating that gene therapy targeting Ezrin alone could be insufficient for imhereditary muscle atrophy.